Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1807 - Therapeutical potential of NRF2 inhibition by Brusatol in Chronic lymphocytic leukemia and in combination with current therapy

    Primary Author / Presenter(s)

  • Sofia Gonçalves, Master in medicine/ MD

    Medical student
    Faculty of Medicine University of Coimbra (FMUC), Coimbra, Portugal

    • Co-Author(s)

  • JJ

    Joana Jorge, PhD

    Faculty of Medicine University of Coimbra (FMUC), Coimbra, Portugal, Laboratory of Oncobiology and Hematology (LOH) and University Clinics of Hematology and Oncology, Coimbra Institute for Clinical and Biomedical Research (iCBR/CIMAGO), Faculty of Medicine University of Coimbra (FMUC), Coimbra, Portugal; Center for Innovative Biomedicine and Biotecnology (CIBB), Coimbra, Portugal, Clinical Academic Centre of Coimbra (CACC), Coimbra, Portugal

  • RG

    Rui F. Gomes, MSc

    Student
    Faculty of Medicine, University of Coimbra, Coimbra, Portugal

  • RA

    Raquel Alves, PhD

    Faculty of Medicine University of Coimbra (FMUC); Laboratory of Oncobiology and Hematology (LOH) and University Clinics of Hematology and Oncology, Coimbra Institute for Clinical and Biomedical Research (iCBR/CIMAGO), Faculty of Medicine University of Coimbra (FMUC); Center for Innovative Biomedicine and Biotecnology (CIBB); Clinical Academic Centre of Coimbra (CACC), Coimbra, Portugal

  • AG

    Ana Cristina Gonçalves, PhD

    Faculty of Medicine University of Coimbra (FMUC); Laboratory of Oncobiology and Hematology (LOH) and University Clinics of Hematology and Oncology, Coimbra Institute for Clinical and Biomedical Research (iCBR/CIMAGO), Faculty of Medicine University of Coimbra (FMUC); Center for Innovative Biomedicine and Biotecnology (CIBB); Clinical Academic Centre of Coimbra (CACC), Coimbra, Portugal

  • JC

    José Pedro Carda, MD

    Lisbon Luz Hospital, Lisbon, Portugal
    Lisboa, Lisboa, Portugal

  • AS

    Ana Bela Sarmento-Ribeiro, PhD

    Laboratory of Oncobiology and Hematology and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

  • SD

    Sara Duarte, MD, PhD

    Faculty of Medicine University of Coimbra (FMUC); Laboratory of Oncobiology and Hematology (LOH) and University Clinics of Hematology and Oncology,Coimbra Institute for Clinical and Biomedical Research (iCBR/CIMAGO), Faculty of Medicine University of Coimbra (FMUC); Center for Innovative Biomedicine and Biotecnology (CIBB); Clinical Academic Centre of Coimbra (CACC); Hematology Service, Unidade Local de Saúde de Coimbra/Centro Hospitalar e Universitário de Coimbra (ULSC/CHUC), Portugal